WHO ICTRP trial
Butorphanol as an adjuvant to Ropivacaine for post operative pain management in…
CTRI/2025/05/086169 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/05/086169 |
|---|---|
| Public title | Butorphanol as an adjuvant to Ropivacaine for post operative pain management in knee arthroscopic surgery , a prospective randomised interventional study |
| Scientific title | Comparison of different doses of Butorphanol as adjuvant with Ropivacaine for single shot Adductor canal block in knee Arthroscopic surgery - nil |
| Primary sponsor | Swami Rama Himalayan University |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: M238- Other internal derangements of knee |
| Interventions | Intervention1: Addition of butorphanol: The other two groups , group R1 will be having ropivacaine 0.2%,19ml with 1mg/ml of butorphanol and group R2 will be having ropivacaine0.2%, 19ml with 2mg/ml of butorphanol which will be given post… |
| Registration date | Feb 5, 2025 |
| Target size | 75 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: